Zoledronic acid, or CGP 42'446, is a third generation, nitrogen containing bisphosphonate similar to ibandronic acid, minodronic acid, and risedronic acid. Zoledronic acid is used to treat and prevent multiple forms of osteoporosis, hypercalcemia of malignancy, multiple myeloma, bone metastases from solid tumors, and Paget’s disease of bone. Zoledronic acid ...
Zoledronic acid is indicated to treat hypercalcemia of malignancy, multiple myeloma, bone metastases from solid tumors, osteoporosis in men and postmenopausal women, glucocorticoid induced osteoporosis, and Paget's disease of bone in men and women. Zoledronic acid is also indicated for the prevention of osteoporosis in post menopausal women and glucocorticoi...
Children's Hospital Medical Center, Cincinnati, Ohio, United States
UCLA - Division of Pediatric Nephrology, Los Angeles, California, United States
Texas Children's Hosptial, Houston, Texas, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Ireland Cancer Center, Cleveland, Ohio, United States
John H. Stroger Hospital of Cook County, Chicago, Illinois, United States
Northwestern University, Chicago, Illinois, United States
Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
Mayo Clinic, Rochester, Minnesota, United States
Carl and Dorothy Bennett Cancer Center at Stamford Hospital, Stamford, Connecticut, United States
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States
Valley Hospital - Paramus, Paramus, New Jersey, United States
Veterans Affairs Medical Center - Pittsburgh, Pittsburgh, Pennsylvania, United States
CCOP - Scott and White Hospital, Temple, Texas, United States
Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States
Kent General Hospital at Bayhealth Medical Center, Dover, Delaware, United States
Galesburg Clinic, Galesburg, Illinois, United States
Suniti Medical Corporation, Merrillville, Indiana, United States
Novartis Investigative Site, Vale of Glamorgan, United Kingdom
Novartis investigative site, Pernarth, United Kingdom
Novartis Investigative site, Penarth, United Kingdom
FL Community Cancer Center, Brooksville, Florida, United States
Eastern Connecticut Hematology/Oncology Associates, Norwich, Connecticut, United States
Elmhurst Memorial Hospital, Elhurst, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.